Specialized Program Of Research Excellence (SPORE) in Leukemia
Specialized Program Of Research Excellence (SPORE) in Leukemia
批准号:
9042603
负责人:
Daniel C Link
金额:
$5.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-03 至 2016-06-30
关键词:
Acute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAgreementAllogenicAttenuatedBasic ScienceBiological AssayBiological MarkersBiometryBlast CellBone MarrowCSF3 geneCXCR4 geneCancer Research ProjectCellsClinicalCollaborationsDNA MethylationDecitabineDevelopmentDisabled PersonsDysmyelopoietic SyndromesEpigenetic ProcessFemaleGene Expression ProfileGene MutationGenomeGenomicsGoalsHematopoiesisImmunologyInstitutionIowaLymphomaLymphopoiesisMarrowMentorsMethodsMinorityMolecularMutationOhioPatientsProcessRNA SplicingRecruitment ActivityRegulatory T-LymphocyteResearchResearch InfrastructureResearch PersonnelResourcesSpliced GenesStem cell transplantSyndromeT cell responseTechnologyTestingTrainingTranslational ResearchUniversitiesWashingtoncancer genomecancer genomicscareer developmentchemotherapygraft vs host diseaseinnovationleukemialeukemia treatmentnext generation sequencingnovelnovel strategiesprogramspublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Washington University SPORE in Leukemia is a highly dynamic translational cancer research program that focuses specifically on leukemias and myelodysplastic syndromes (MDS). We have assembled an outstanding group of investigators with complementary expertise in basic and clinical leukemia research. In this SPORE, we leverage expertise in cancer genomics, immunology, and hematopoiesis to develop innovative translational research in leukemia. Our long term goal is to develop novel biomarkers and treatments for leukemias and MDS and to recruit and promote innovative translational leukemia research. To achieve these goals, the following specific aims are proposed.
Aim 1. To exploit recent advances in cancer genomics to develop novel biomarkers and treatments for leukemias and MDS. Washington University has been at the forefront of genomic studies in AML and MDS. Through sequencing of primary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) genomes, we identified several novel recurring mutations of genes involved in DNA methylation (DNMT3A and IDH1) and RNA splicing (U2AF1). This basic research has led to the development of the following two translational SPORE projects.
Project 1. Molecular determinants of decitabine responsiveness
Project 3. Development of RNA splicing modulators for myelodysplastic syndromes and AML.
Aim 2. To leverage local expertise in immunology and hematopoiesis to develop novel treatments for leukemias and myelodvsplastic syndromes. Institutional expertise in basic immunology and hematopoiesis research has led to the development of two innovative translational projects in leukemia.
Project 2. Targeting the bone marrow microenvironment in acute lymphocytic leukemia.
Project 4. Epigenetic modulation of graft versus host disease and graft versus leukemia.
Aim 3. To enhance the infrastructure that supports translational leukemia research. This SPORE will support the following Shared Research Resources: 1) Core A. Biospecimen Processing; 2) Core
B. Biostatistics; and 3) Core C. Administration.
Aim 4. To recruit and train new investigators in translational research.
Aim 5. To facilitate inter-SPORE collaboration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of new genetic causes of congenital neutropenia
-
批准号:10621903
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Daniel C Link
-
依托单位:
Identification of new genetic causes of congenital neutropenia
-
批准号:10159977
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Daniel C Link
-
依托单位:
Identification of new genetic causes of congenital neutropenia
-
批准号:10399626
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Daniel C Link
-
依托单位:
Single Cell Spatial Characterization of the Human Bone Marrow Microenvironment
-
批准号:10115110
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2020
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia.
-
批准号:10439617
-
项目类别:
-
资助金额:$212.79万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Administrative Core
-
批准号:10439618
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia.
-
批准号:9756314
-
项目类别:
-
资助金额:$211.76万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia
-
批准号:9307740
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia.
-
批准号:10194393
-
项目类别:
-
资助金额:$203.6万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Administrative Core
-
批准号:10194394
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
DRP
-
批准号:10194405
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia
-
批准号:8729566
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia
-
批准号:9379028
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia.
-
批准号:10912197
-
项目类别:
-
资助金额:$91.86万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
DRP
-
批准号:10931080
-
项目类别:
-
资助金额:$2.97万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Administrative Core
-
批准号:10931073
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Patient Advocate
-
批准号:8595814
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
DRP
-
批准号:10439628
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Core C: ADMINISTRATION
-
批准号:9093734
-
项目类别:
-
资助金额:$11.23万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
Specialized Program Of Research Excellence (SPORE) in Leukemia
-
批准号:8548461
-
项目类别:
-
资助金额:$215.1万
-
财政年份:2013
-
负责人:Daniel C Link
-
依托单位:
海外基金